246 related articles for article (PubMed ID: 38414247)
21. Alpha-Lipoic Acid Attenuates Apoptosis and Ferroptosis in Cisplatin-Induced Ototoxicity via the Reduction of Intracellular Lipid Droplets.
Cho S; Hong SJ; Kang SH; Park Y; Kim SK
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142894
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
23. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
Li D; Zhang M; Chao H
Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856
[TBL] [Abstract][Full Text] [Related]
24. Apelin-13 protects against cisplatin-induced ototoxicity by inhibiting apoptosis and regulating STAT1 and STAT3.
Yin H; Sun Y; Ya B; Guo Y; Zhao H; Zhang L; Wang F; Zhang W; Yang Q
Arch Toxicol; 2023 Sep; 97(9):2477-2493. PubMed ID: 37395757
[TBL] [Abstract][Full Text] [Related]
25. The intravenous administration of skin-derived mesenchymal stem cells ameliorates hearing loss and preserves cochlear hair cells in cisplatin-injected mice: SMSCs ameliorate hearing loss and preserve outer hair cells in mice.
Tsai SC; Lin FC; Chang KH; Li MC; Chou RH; Huang MY; Chen YC; Kao CY; Cheng CC; Lin HC; Hsu YC
Hear Res; 2022 Jan; 413():108254. PubMed ID: 34020824
[TBL] [Abstract][Full Text] [Related]
26. FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect.
Yao Z; Xiao Y; Li W; Kong S; Tu H; Guo S; Liu Z; Ma L; Qiao R; Wang S; Chang M; Zhao X; Zhang Y; Xu L; Sun D; Fu X
J Assoc Res Otolaryngol; 2024 Jun; 25(3):259-275. PubMed ID: 38622383
[TBL] [Abstract][Full Text] [Related]
27. Puerarin inhibits cisplatin-induced ototoxicity in mice through regulation of TRPV1-dependent calcium overload.
Lin Y; Liang R; Xie K; Ma T; Zhang J; Xu T; Wang A; Liu S
Biochem Pharmacol; 2024 Feb; 220():115962. PubMed ID: 38043717
[TBL] [Abstract][Full Text] [Related]
28. Lipid peroxidation-induced ferroptosis as a therapeutic target for mitigating neuronal injury and inflammation in sepsis-associated encephalopathy: insights into the hippocampal PEBP-1/15-LOX/GPX4 pathway.
Wang H; Xu L; Tang X; Jiang Z; Feng X
Lipids Health Dis; 2024 Apr; 23(1):128. PubMed ID: 38685023
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
[TBL] [Abstract][Full Text] [Related]
30. Aucubin protects mouse cochlear hair cells from cisplatin-induced ototoxicity via activation of the PI3K/AKT/STAT3 pathway.
Jiang Y; Li Z; Ma Q; Dong W; Yao Q; Yu D
Biochem Pharmacol; 2023 Mar; 209():115440. PubMed ID: 36720354
[TBL] [Abstract][Full Text] [Related]
31. Characterization of ferroptosis in kidney tubular cell death under diabetic conditions.
Kim S; Kang SW; Joo J; Han SH; Shin H; Nam BY; Park J; Yoo TH; Kim G; Lee P; Park JT
Cell Death Dis; 2021 Feb; 12(2):160. PubMed ID: 33558472
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells.
Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R
Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts.
Zhang F; Xiao Y; Huang Z; Wang Y; Wan W; Zou H; Wang B; Qiu X; Yang X
Free Radic Biol Med; 2024 Aug; 221():23-30. PubMed ID: 38740100
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
[No Abstract] [Full Text] [Related]
35. Dauricine alleviated secondary brain injury after intracerebral hemorrhage by upregulating GPX4 expression and inhibiting ferroptosis of nerve cells.
Peng C; Fu X; Wang K; Chen L; Luo B; Huang N; Luo Y; Chen W
Eur J Pharmacol; 2022 Jan; 914():174461. PubMed ID: 34469757
[TBL] [Abstract][Full Text] [Related]
36. The protective role of ferulic acid against cisplatin-induced ototoxicity.
Jo ER; Youn CK; Jun Y; Cho SI
Int J Pediatr Otorhinolaryngol; 2019 May; 120():30-35. PubMed ID: 30753979
[TBL] [Abstract][Full Text] [Related]
37. Peroxiredoxin 6 suppresses ferroptosis in lung endothelial cells.
Torres-Velarde JM; Allen KN; Salvador-Pascual A; Leija RG; Luong D; Moreno-Santillán DD; Ensminger DC; Vázquez-Medina JP
Free Radic Biol Med; 2024 Jun; 218():82-93. PubMed ID: 38579937
[TBL] [Abstract][Full Text] [Related]
38. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
[TBL] [Abstract][Full Text] [Related]
40. Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy.
Benkafadar N; Menardo J; Bourien J; Nouvian R; François F; Decaudin D; Maiorano D; Puel JL; Wang J
EMBO Mol Med; 2017 Jan; 9(1):7-26. PubMed ID: 27794029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
